Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huayu Quban Capsules is a traditional Chinese medicine (TCM) developed by Tianjin Hong Ren Tang Pharmaceutical for the treatment of hyperpigmentation, specifically chloasma (melasma). The formulation is designed to address the TCM patterns of liver qi stagnation and blood stasis, which are believed to manifest as dark spots on the skin. By promoting blood circulation, resolving stasis, and nourishing the liver and kidneys, the capsules aim to reduce pigmentation and improve skin complexion. It is an approved oral medication in China, often containing a complex mixture of herbal ingredients such as Salvia miltiorrhiza, Angelica sinensis, and Bupleurum.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huayu Quban Capsules.